INFUSION SITE JOINT MOVEMENT IMPAIRMENT

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting INFUSION SITE JOINT MOVEMENT IMPAIRMENT:

# Drug Count
0 BLEOMYCIN 4
1 BLEOMYCIN SULFATE 4
2 DACARBAZINE 4
3 DOXORUBICIN 4
4 CYCLOPHOSPHAMIDE 2
5 CYCLOPHOSPHAMIDE FOR INJECTION 2
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 2
7 ALBUTEROL SULFATE 1
8 ASPIRIN 1
9 ASPIRIN 325 MG 1
See all common drugs associated with INFUSION SITE JOINT MOVEMENT IMPAIRMENT

INFUSION SITE JOINT MOVEMENT IMPAIRMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACARBAZINE 4 0.0005
1 VINBLASTINE SULFATE 1 0.0005
2 BLEOMYCIN SULFATE 4 0.0004
3 LEVONORGESTREL AND ETHINYL ESTRADIOL 1 0.0004
4 EPIRUBICIN HYDROCHLORIDE 1 0.0002
5 HYOSCYAMINE SULFATE 1 0.0001
6 EPTINEZUMAB-JJMR 1 0.0001
7 BENDAMUSTINE HCL 1 0.0001
8 DOXORUBICIN 4 0.0000
9 DOXORUBICIN HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with INFUSION SITE JOINT MOVEMENT IMPAIRMENT

INFUSION SITE JOINT MOVEMENT IMPAIRMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin Gene-related Peptide Antagonist [EPC] 1 0.0001
1 Alkylating Drug [EPC] 6 0.0000
2 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
3 Platelet Aggregation Inhibitor [EPC] 1 0.0000
4 Proton Pump Inhibitor [EPC] 1 0.0000
5 Benzodiazepine [EPC] 1 0.0000
6 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with INFUSION SITE JOINT MOVEMENT IMPAIRMENT